MYPROMS-ES02: SAFETY AND EFFICACY OF BASILIXIMAB, CYCLOSPORINE MICROEMULSION AND ENTERIC-COATED MYCOPHENOLATE SODIUM (EC-MPS) VERSUS EC-MPS AND STEROID THERAPY IN KIDNEY TRANSPLANT RECIPIENTS WHO ARE HEPATITIS C POSITIVE: